Concepedia

Heidi McIntyre

HM

Statistics

Publications

4

Citations

1.5K

H-Index

4

Active since

2007

Affiliations

Princess Margaret Cancer Centre(Current)

Samsung Medical Center

University Hospital Ulm

Hôpital Saint-Louis

Harvard University

Heidi McIntyre is an author at Princess Margaret Cancer Centre specializing in pharmacotherapy, chemotherapy, and medicine.

Publications per year

2007–2015

4

Publications

4

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Hervé Dombret, John F. Seymour, Aleksandra Butrym et al. · Blood · 2015 · 1.1K citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +2

Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes

Roger M. Lyons, Thomas M. Cosgriff, Sanjiv Modi et al. · Journal of Clinical Oncology · 2009 · 272 citations

Medicine, Pharmacology, Pharmacotherapy +17

Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza®) in Patients with Myelodysplastic Syndromes (MDS).

Roger M. Lyons, Thomas M. Cosgriff, Sanjiv Modi et al. · Blood · 2007 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +12

Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (>30% Bone Marrow Blasts) with Morphologic Dysplastic Changes: A Subgroup Analysis of the AZA-AML-001 Trial

John F. Seymour, Hartmut Döhner, Aleksandra Butrym et al. · Blood · 2014 · 14 citations

Medicine, Oncology, Pharmacotherapy +13

1–4 of 4